Here are five strategies for how healthcare providers can use claims, clinical data and benchmarking services to maximize their potential with payers.
Shamron Wilder的动态
最相关的动态
-
Our latest Insight post explores how teamwork across departments and innovative technologies can streamline compliance efforts. Discover more in our latest post, "Innovative Approaches to Compliance Reviews: A Playbook for Healthcare Payers." Read the full post now: https://lnkd.in/eS5r-mna #HealthcareCompliance #ComplianceReviews #BHMHealthcareSolutions
要查看或添加评论,请登录
-
-
In the face of new price transparency mandates, Payers can feel stuck maintaining the status quo when it comes to re-pricing approaches. But they can break free.? Read our new infographic to learn about the differences between traditional re-pricing methodologies and new, transparent and dynamic, data-driven pricing that Payers can leverage to maintain regulatory compliance and optimize healthcare spending while ensuring access to quality, affordable care:??https://lnkd.in/g6P8vRVC??
要查看或添加评论,请登录
-
-
ONC HTI-2 Proposed Rule: A Leap Forward in Healthcare Interoperability By Kim Boyd - This game-changing proposal aims to significantly advance interoperability and improve information sharing among patients, providers, payers, and #publichealth authorities. Let's dive into the key aspects of this transformative rule. Point-of-Care Partners #interoperability https://lnkd.in/e-twwzd9
要查看或添加评论,请登录
-
-
As the discussion around prior authorization evolves within the healthcare industry, the AMA presents compelling arguments for essential considerations. This article examines key factors, such as expediting payer response times, reducing the number of prior authorization submissions, and enhancing transparency around the key question, "is auth required?" It also emphasizes the importance of involving physicians in discussions with payers about best practices in prior authorization. https://lnkd.in/g7UkeXBY #priorauth #healthcareAI #priorauthorization
要查看或添加评论,请登录
-
-
As the discussion around prior authorization evolves within the healthcare industry, the AMA presents compelling arguments for essential considerations. This article examines key factors, such as expediting payer response times, reducing the number of prior authorization submissions, and enhancing transparency around the key question, "is auth required?" It also emphasizes the importance of involving physicians in discussions with payers about best practices in prior authorization. https://lnkd.in/g4jVu6Cb #priorauth #healthcareAI #priorauthorization
要查看或添加评论,请登录
-
-
As the discussion around prior authorization evolves within the healthcare industry, the AMA presents compelling arguments for essential considerations. This article examines key factors, such as expediting payer response times, reducing the number of prior authorization submissions, and enhancing transparency around the key question, "is auth required?" It also emphasizes the importance of involving physicians in discussions with payers about best practices in prior authorization. https://lnkd.in/dFW9Zy8r #priorauth #healthcareAI #priorauthorization
要查看或添加评论,请登录
-
-
Are you ready for the upcoming regulatory changes in the healthcare industry? Discover how leveraging cutting-edge technology can help health payers stay ahead of the curve. Dive into our latest blog to explore actionable insights and strategies. Read more: https://bit.ly/4dlD7Qn #HealthTech #RegulatoryCompliance #HealthcareInnovation #HealthPayers #TechTrends
Health Payers Need to Leverage New Technology to Prepare for Regulatory Changes Ahead
insights.vitaldatatechnology.com
要查看或添加评论,请登录
-
As healthcare shifts towards value-based care, adapting your revenue cycle strategies is essential. Discover how to optimize your practice for value-based reimbursement, navigate challenges, and implement best practices for a seamless transition. Embrace the future of healthcare today: https://ow.ly/c2II50Slg36 #ValueBasedCare #RevenueCycleManagement #HealthcareFinance
Preparing for Value-Based Reimbursement - Adapting Revenue Cycle Strategies for the Future
drchrono.com
要查看或添加评论,请登录
-
A great case study in how to stop the massive Rx Revenue loss for pharmaceutical brands, while improving outcomes and experience for patiets and HCPs. Different approaches lead to different outcomes. Predictive and proactive market access and commercialization, a first for pharma...with a little help from AI :)
Across the healthcare landscape, a staggering 20–30% of prescriptions go unfilled, leading to a $150 billion challenge impacting patients, healthcare providers (HCPs), payers, and the choice of treatment options. By implementing intelligent AI-driven solutions that anticipate and address access barriers, we can create a “Win4All” scenario where each key stakeholder group experiences their unique benefits. Read more from Ellen Cappellino and ? Ryan Slipakoff: https://bit.ly/3xfBhRV
要查看或添加评论,请登录
-
-
Real World Evidence (RWE) provides payers with a powerful tool to help identify the value of therapies for reimbursement. Our most recent whitepaper, authored by members of the Real World Evidence Leadership Forum, explores the benefits and challenges to the widespread adoption of #RWE in healthcare decision-making in the US market. https://lnkd.in/dz-84-Wn
要查看或添加评论,请登录
-